Pharmaron Beijing Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Pharmaron Beijing has a total shareholder equity of CN¥14.0B and total debt of CN¥5.4B, which brings its debt-to-equity ratio to 38.7%. Its total assets and total liabilities are CN¥23.6B and CN¥9.5B respectively. Pharmaron Beijing's EBIT is CN¥1.5B making its interest coverage ratio -3.4. It has cash and short-term investments of CN¥2.6B.
Anahtar bilgiler
38.7%
Borç/özkaynak oranı
CN¥5.43b
Borç
| Faiz karşılama oranı | -3.4x |
| Nakit | CN¥2.60b |
| Eşitlik | CN¥14.03b |
| Toplam yükümlülükler | CN¥9.54b |
| Toplam varlıklar | CN¥23.57b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 3759's short term assets (CN¥7.1B) exceed its short term liabilities (CN¥4.2B).
Uzun Vadeli Yükümlülükler: 3759's short term assets (CN¥7.1B) exceed its long term liabilities (CN¥5.4B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 3759's net debt to equity ratio (20.2%) is considered satisfactory.
Borcun Azaltılması: 3759's debt to equity ratio has reduced from 48.6% to 38.7% over the past 5 years.
Borç Kapsamı: 3759's debt is well covered by operating cash flow (46%).
Faiz Kapsamı: 3759 earns more interest than it pays, so coverage of interest payments is not a concern.